Evidence map›Paper›PMID 23703609›Full record

ArticleThe Journal of biological chemistry2013

TORC2 is required to maintain genome stability during S phase in fission yeast.

Miriam Schonbrun, Masha Kolesnikov, Martin Kupiec, Ronit Weisman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Genome Profiling for Aflatoxin BG3 (Bethesda, Md.) · 2020
    Article
  11. Article
  12. Review
  13. Functional Impacts of the BRCA1-mTORC2 Interaction in Breast Cancer.International journal of molecular sciences · 2019
    Article
  14. The TOR pathway modulates cytoophidium formation inThe Journal of biological chemistry · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miriam SchonbrunDepartment of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv, Israel.
Masha Kolesnikov
Martin Kupiec
Ronit Weisman
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA damage can occur due to environmental insults or intrinsic metabolic processes and is a major threat to genome stability. The DNA damage response is composed of a series of well coordinated cellular processes that include activation of the DNA damage checkpoint, transient cell cycle arrest, DNA damage repair, and reentry into the cell cycle. Here we demonstrate that mutant cells defective for TOR complex 2 (TORC2) or the downstream AGC-like kinase, Gad8, are highly sensitive to chronic replication stress but are insensitive to ionizing radiation. We show that in response to replication stress, TORC2 is dispensable for Chk1-mediated cell cycle arrest but is required for the return to cell cycle progression. Rad52 is a DNA repair and recombination protein that forms foci at DNA damage sites and stalled replication forks. TORC2 mutant cells show increased spontaneous nuclear Rad52 foci, particularly during S phase, suggesting that TORC2 protects cells from DNA damage that occurs during normal DNA replication. Consistently, the viability of TORC2-Gad8 mutant cells is dependent on the presence of the homologous recombination pathway and other proteins that are required for replication restart following fork replication stalling. Our findings indicate that TORC2 is required for genome integrity. This may be relevant for the growing amount of evidence implicating TORC2 in cancer development.

Indexed as

Genome, FungalGenomic InstabilityMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesMutationProtein Serine-Threonine KinasesRad52 DNA Repair and Recombination ProteinSchizosaccharomycesSchizosaccharomyces pombe ProteinsS PhaseTOR Serine-Threonine KinasesGad8 protein, S pombeMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesProtein Serine-Threonine KinasesRad52 DNA Repair and Recombination ProteinSchizosaccharomyces pombe ProteinsTOR Serine-Threonine KinasesDNA Damage ResponseFission YeastMolecular Cell BiologyRapamycinSignal TransductionS. pombeStressTORC2Yeast Genetics

Identifiers

PMID23703609
PMCPMC3707671
OpenAlexW2094200623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.